Benazeprilat

This classification denotes an ace inhibitor with the molecular formula C22H24N2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier JRM708L703, chemically known as 1h-1-benzazepine-1-acetic acid, 3-(((1s)-1-carboxy-3-phenylpropyl)amino)-2,3,4,5-tetrahydro-2-oxo-, (3s)- but generally known as benazeprilat, which bears US NIH Compound Identifier 5463984. European Medicines Agency schedules Benazeprilat in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05701MIG. The term BENAZEPRILAT is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 2, No. 3, 1988, List 28). BENAZEPRILAT is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule benazeprilat under HS 29337900 and SITC 51561. As of Q4 2014, BENAZEPRILAT remains the US FDA Preferred Term for this commodity. Benazeprilat bears US NLM identifiers UMLS ID C0105523 and NCI Concept Code C72907. SMILES: O=C1N(c2c(CCC1NC(CCc1ccccc1)C(=O)O)cccc2)CC(=O)O.